Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nexium

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

Leading AstraZeneca’s return to growth in Europe

Leading AstraZeneca’s return to growth in Europe

doldrums due to the expiry of old blockbusters such as Nexium and Crestor.

AstraZeneca’s oncology renaissance

AstraZeneca’s oncology renaissance This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on

China: AstraZeneca’s new engine for growth and innovation

China: AstraZeneca’s new engine for growth and innovation years for AZ to return to top-line growth after the patent loss of blockbuster brands such as Nexium and Crestor.

AZ expects return to growth this year after 2017 decline

AZ expects return to growth this year after 2017 decline to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.

AZ sells Zurampic rights to Gruenenthal for $230m

AZ sells Zurampic rights to Gruenenthal for $230m light of the loss of patent protection for blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics